首頁 > 市場調查報告書 > 醫療設備

手術用器具

神經外科市場規模、佔有率和成長分析（按產品、年齡層、適應症、分銷管道、最終用戶和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898220

神經外科市場規模、佔有率和成長分析（按產品、年齡層、適應症、分銷管道、最終用戶和地區分類）—產業預測（2026-2033 年）

Neurosurgery Market Size, Share, and Growth Analysis, By Product (Neuro Interventional Devices, Neuroendoscopes), By Age Group (Pediatric, Adult), By Indication, By Distribution Channel, By End-user, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球神經外科市場規模將達到 45 億美元，到 2025 年將達到 47 億美元，到 2033 年將達到 67.4 億美元，預測期（2026-2033 年）的複合年成長率為 4.6%。

全球神經外科市場正經歷顯著成長，這主要得益於多種促進因素。神經外科技術和設備的創新使得手術更加精準、微創，從而改善患者預後並縮短復原時間。此外，人口老化以及神經系統疾病盛行率的上升也推動了對神經外科服務的需求。醫療機構與製藥公司之間的合作促進了治療技術的進步。然而，諸如專業培訓和昂貴設備等高進入門檻可能會阻礙新進入者。總體而言，隨著神經外科不斷適應全球醫療保健需求的變化，預計該領域將持續成長。

全球神經外科市場促進因素

全球神經外科市場的主要促進因素是中風、創傷性腦損傷和腫瘤等神經系統疾病的日益增加。隨著世界人口老化，預計這些疾病的發生率將持續上升，從而推動對神經外科手術的需求。此外，微創手術和先進影像技術等外科技術的進步正在改善患者的治療效果，並促進早期診斷和治療。人們對神經系統健康重要性的認知不斷提高，以及新興經濟體醫療基礎設施的不斷完善，也為市場成長潛力做出了貢獻，為神經外科領域的創新和發展創造了有利環境。

全球神經外科市場阻礙因素

全球神經外科市場面臨的主要限制因素之一是手術費用和先進醫療技術高成本。神經外科手術通常涉及複雜的介入操作，需要專用設備和訓練有素的人員，導致營運成本增加。醫院和醫療機構面臨預算限制，這可能會限制其投資尖端技術和擴展外科服務的能力。此外，患者可能面臨接受必要神經外科治療的經濟障礙，尤其是在醫療資源有限的地區。這些高成本，加上經濟可及性的挑戰，可能會阻礙市場成長和創新神經外科解決方案的推廣應用。

全球神經外科市場趨勢

全球神經外科市場正經歷著向微創技術的顯著轉變，這主要受患者對能夠縮短恢復時間、減少術後併發症的手術方式的需求不斷成長的推動。機器人手術和影像導引系統等先進技術的應用提高了手術的精準性和安全性，進一步促進了醫療機構和病患的接受度。隨著外科醫生在追求改善治療效果的同時盡可能減少創傷，向微創技術的轉變預計將重塑神經外科的格局，並推動手術器械和技術的創新，以滿足這種以患者為中心的醫療服務偏好。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Elekta（Sweden）
ALEVA NEUROTHERAPEUTICS（Switzerland）
Machida Endoscope Co., Ltd.（Japan）
Brainlab AG（Germany）
adeor medical AG.（Germany）
LivaNova PLC（UK）
B. Braun SE（Germany）
Optofine Instruments Pvt. Ltd.（India）
Wallaby Medical（Australia）
Terumo Medical Corporation（Japan）
NEVRO CORP.（US）
Integra LifeSciences（US）
Stryker（US）
Penumbra, Inc.（US）
KARL STORZ SE & Co. KG（Germany）
Nalu Medical, Inc.（US）
Renishaw plc.（UK）
Synapse Biomedical Inc.（US）
EMS Handels Gesellschaft mbH（Germany）
Inomed Medizintechnik GmbH（Germany）

結論與建議

簡介目錄

Product Code: SQMIG35G2274

Global Neurosurgery Market size was valued at USD 4.5 Billion in 2024 and is poised to grow from USD 4.7 Billion in 2025 to USD 6.74 Billion by 2033, growing at a CAGR of 4.6% during the forecast period (2026-2033).

The global neurosurgery market is experiencing significant growth due to several driving factors. Innovations in neurosurgical techniques and devices have led to more precise and minimally invasive procedures, enhancing patient outcomes and reducing recovery periods. Furthermore, an increasingly aging population, coupled with a heightened prevalence of neurological disorders, has elevated the demand for neurosurgical services. Collaborative efforts between healthcare institutions and pharmaceutical companies are fostering advancements in treatment methodologies. Nonetheless, the market faces high entry barriers attributed to the necessity for specialized training and costly equipment, potentially hindering new market entrants. Overall, the neurosurgery sector is set for continuous growth as it adapts to meet the evolving healthcare demands of a global population.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurosurgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurosurgery Market Segments Analysis

Global Neurosurgery Market is segmented by Product, Age Group, Indication, Distribution Channel, End-user and region. Based on Product, the market is segmented into Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes, Neurosurgical Ablation Devices and Neurosurgery Instruments. Based on Age Group, the market is segmented into Pediatric, Adult and Geriatric. Based on Indication, the market is segmented into Brain Cancer, Spine and Skull base Tumors, Traumatic Brain Injuries, Craniofacial Trauma, Parkinson's Disease, Tourette's Syndrome and Others. Based on Distribution Channel, the market is segmented into Direct tender, Third party distributors and Others. Based on End-user, the market is segmented into Hospitals & Specialty Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neurosurgery Market

A key market driver for the global neurosurgery market is the rising prevalence of neurological disorders, including stroke, traumatic brain injuries, and tumors. As the global population ages, the incidence of these conditions is expected to increase, leading to a higher demand for neurosurgical interventions. Additionally, advancements in surgical techniques, such as minimally invasive procedures and enhanced imaging technologies, are improving patient outcomes and encouraging earlier diagnosis and treatment. The growing awareness of the importance of neurological health and the expansion of healthcare infrastructure in emerging economies further contribute to the market's growth potential, fostering an environment for innovation and development in neurosurgery.

Restraints in the Global Neurosurgery Market

One significant market restraint for the global neurosurgery market is the high cost of surgical procedures and advanced medical technologies. Neurosurgery often involves complex interventions that require specialized equipment and highly trained personnel, leading to increased operational costs. Hospitals and healthcare facilities may face budget constraints that limit their ability to invest in the latest technologies or expand their surgical services. Moreover, patients may experience financial barriers to accessing necessary neurosurgical treatments, particularly in regions with limited healthcare funding. This combination of high costs and financial accessibility challenges can hinder market growth and the adoption of innovative neurosurgical solutions.

Market Trends of the Global Neurosurgery Market

The global neurosurgery market is witnessing a significant trend towards minimally invasive techniques, driven by heightened patient demand for procedures that reduce recovery time and postoperative complications. The adoption of advanced technologies, including robotic surgery and image-guided systems, enhances the precision and safety of these interventions, further encouraging their popularity among both healthcare providers and patients. As surgeons increasingly seek to improve outcomes while minimizing trauma, the shift towards less invasive methodologies is anticipated to reshape the neurosurgery landscape, leading to innovations in surgical instruments and techniques that align with this growing preference for patient-centric care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global Neurosurgery Market Size by Product & CAGR (2026-2033)

Market Overview
Neuro Interventional Devices
Neuroendoscopes
Neurosurgical Drills
Radiosurgery Systems
Dura Substitutes
Neurosurgical Ablation Devices
Neurosurgery Instruments

Global Neurosurgery Market Size by Age Group & CAGR (2026-2033)

Market Overview
Pediatric
Adult
Geriatric

Global Neurosurgery Market Size by Indication & CAGR (2026-2033)

Market Overview
Brain Cancer
Spine and Skull base Tumors
Traumatic Brain Injuries
Craniofacial Trauma
Parkinson's Disease
Tourette's Syndrome
Others

Global Neurosurgery Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Direct tender
Third party distributors
Others

Global Neurosurgery Market Size by End-user & CAGR (2026-2033)

Market Overview
Hospitals & Specialty Clinics
Ambulatory Surgical Centers
Others

Global Neurosurgery Market Size & CAGR (2026-2033)

North America (Product, Age Group, Indication, Distribution Channel, End-user)
- US
- Canada
Europe (Product, Age Group, Indication, Distribution Channel, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Age Group, Indication, Distribution Channel, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Age Group, Indication, Distribution Channel, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Age Group, Indication, Distribution Channel, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Elekta (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ALEVA NEUROTHERAPEUTICS (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Machida Endoscope Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brainlab AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
adeor medical AG. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Optofine Instruments Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wallaby Medical (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Medical Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NEVRO CORP. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KARL STORZ SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nalu Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Renishaw plc. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synapse Biomedical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EMS Handels Gesellschaft mbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inomed Medizintechnik GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments